IOSP Quote, Financials, Valuation and Earnings

Aemetis, Inc. has a net margin of 2.92% compared to Innospec, Inc.'s net margin of -40.12%. Innospec, Inc.'s return on equity of -0.1% beat Aemetis, Inc.'s return on equity of --.

Innospec, Inc. has a consensus price target of $99.33, signalling upside risk potential of 32.71%. On the other hand Aemetis, Inc. has an analysts' consensus of $13.38 which suggests that it could grow by 720.55%. Given that Aemetis, Inc. has higher upside potential than Innospec, Inc., analysts believe Aemetis, Inc. is more attractive than Innospec, Inc..

Innospec, Inc. has a beta of 0.931, which suggesting that the stock is 6.907% less volatile than S&P 500. In comparison Aemetis, Inc. has a beta of 2.288, suggesting its more volatile than the S&P 500 by 128.783%.

Innospec, Inc. has a quarterly dividend of $0.87 per share corresponding to a yield of 2.29%. Aemetis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innospec, Inc. pays 109.37% of its earnings as a dividend. Aemetis, Inc. pays out -- of its earnings as a dividend.

Innospec, Inc. quarterly revenues are $441.9M, which are larger than Aemetis, Inc. quarterly revenues of $59.2M. Innospec, Inc.'s net income of $12.9M is higher than Aemetis, Inc.'s net income of -$23.7M. Notably, Innospec, Inc.'s price-to-earnings ratio is 98.17x while Aemetis, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec, Inc. is 1.05x versus 0.44x for Aemetis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Balchem Corp. has a net margin of 2.92% compared to Innospec, Inc.'s net margin of 15.06%. Innospec, Inc.'s return on equity of -0.1% beat Balchem Corp.'s return on equity of 12.23%.

Innospec, Inc. has a consensus price target of $99.33, signalling upside risk potential of 32.71%. On the other hand Balchem Corp. has an analysts' consensus of $200.67 which suggests that it could grow by 30.86%. Given that Innospec, Inc. has higher upside potential than Balchem Corp., analysts believe Innospec, Inc. is more attractive than Balchem Corp..

Innospec, Inc. has a beta of 0.931, which suggesting that the stock is 6.907% less volatile than S&P 500. In comparison Balchem Corp. has a beta of 0.992, suggesting its less volatile than the S&P 500 by 0.809%.

Innospec, Inc. has a quarterly dividend of $0.87 per share corresponding to a yield of 2.29%. Balchem Corp. offers a yield of 0.57% to investors and pays a quarterly dividend of $0.87 per share. Innospec, Inc. pays 109.37% of its earnings as a dividend. Balchem Corp. pays out 22.16% of its earnings as a dividend. Balchem Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Innospec, Inc.'s is not.

Innospec, Inc. quarterly revenues are $441.9M, which are larger than Balchem Corp. quarterly revenues of $267.6M. Innospec, Inc.'s net income of $12.9M is lower than Balchem Corp.'s net income of $40.3M. Notably, Innospec, Inc.'s price-to-earnings ratio is 98.17x while Balchem Corp.'s PE ratio is 33.57x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec, Inc. is 1.05x versus 4.94x for Balchem Corp.. Usually stocks with elevated PS ratios are considered overvalued.

The Chemours Co. has a net margin of 2.92% compared to Innospec, Inc.'s net margin of 4.01%. Innospec, Inc.'s return on equity of -0.1% beat The Chemours Co.'s return on equity of -69.66%.

Innospec, Inc. has a consensus price target of $99.33, signalling upside risk potential of 32.71%. On the other hand The Chemours Co. has an analysts' consensus of $15.78 which suggests that it could grow by 25.82%. Given that Innospec, Inc. has higher upside potential than The Chemours Co., analysts believe Innospec, Inc. is more attractive than The Chemours Co..

Innospec, Inc. has a beta of 0.931, which suggesting that the stock is 6.907% less volatile than S&P 500. In comparison The Chemours Co. has a beta of 1.593, suggesting its more volatile than the S&P 500 by 59.275%.

Innospec, Inc. has a quarterly dividend of $0.87 per share corresponding to a yield of 2.29%. The Chemours Co. offers a yield of 4.09% to investors and pays a quarterly dividend of $0.09 per share. Innospec, Inc. pays 109.37% of its earnings as a dividend. The Chemours Co. pays out 174.61% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Innospec, Inc. quarterly revenues are $441.9M, which are smaller than The Chemours Co. quarterly revenues of $1.5B. Innospec, Inc.'s net income of $12.9M is lower than The Chemours Co.'s net income of $60M. Notably, Innospec, Inc.'s price-to-earnings ratio is 98.17x while The Chemours Co.'s PE ratio is 66.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec, Inc. is 1.05x versus 0.32x for The Chemours Co.. Usually stocks with elevated PS ratios are considered overvalued.

WD-40 Co. has a net margin of 2.92% compared to Innospec, Inc.'s net margin of 12.96%. Innospec, Inc.'s return on equity of -0.1% beat WD-40 Co.'s return on equity of 37.06%.

Innospec, Inc. has a consensus price target of $99.33, signalling upside risk potential of 32.71%. On the other hand WD-40 Co. has an analysts' consensus of $264.50 which suggests that it could grow by 35.71%. Given that WD-40 Co. has higher upside potential than Innospec, Inc., analysts believe WD-40 Co. is more attractive than Innospec, Inc..

Innospec, Inc. has a beta of 0.931, which suggesting that the stock is 6.907% less volatile than S&P 500. In comparison WD-40 Co. has a beta of 0.158, suggesting its less volatile than the S&P 500 by 84.229%.

Innospec, Inc. has a quarterly dividend of $0.87 per share corresponding to a yield of 2.29%. WD-40 Co. offers a yield of 1.93% to investors and pays a quarterly dividend of $0.94 per share. Innospec, Inc. pays 109.37% of its earnings as a dividend. WD-40 Co. pays out 55.33% of its earnings as a dividend. WD-40 Co.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Innospec, Inc.'s is not.

Innospec, Inc. quarterly revenues are $441.9M, which are larger than WD-40 Co. quarterly revenues of $163.5M. Innospec, Inc.'s net income of $12.9M is lower than WD-40 Co.'s net income of $21.2M. Notably, Innospec, Inc.'s price-to-earnings ratio is 98.17x while WD-40 Co.'s PE ratio is 29.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec, Inc. is 1.05x versus 4.27x for WD-40 Co.. Usually stocks with elevated PS ratios are considered overvalued.